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Previous meta-analysis indicated conflicting results in case–control versus cohort studies on the association of
green tea with breast cancer risk, and conflicting results were also found in case–control versus cohort studies in
another meta-analysis on the association of black tea with breast cancer risk. Many studies were published after the
previous meta-analysis. Besides, the dose-response relationship of tea consumption with breast cancer risk is
unclear. Thus the association of tea consumption with breast cancer risk was assessed incorporating new
publications. Summary relative risk (RR) for highest versus lowest level of tea consumption was calculated based on
fixed or random effect models. Dose-response relationship was assessed by restricted cubic spline model and
multivariate random-effect meta-regression. The combined results from 9 studies suggested no significant
association between green tea consumption and breast cancer risk (RR = 0.82, 95% CI = 0.64-1.04). No significant
association was found among cohort studies and case-control studies after sensitivity analysis, respectively. A linear
but not significant dose-response association was found between green tea consumption and breast cancer risk.
The combined results from 25 studies demonstrated no significant association between black tea consumption and
breast cancer risk (RR = 0.98, 95% CI = 0.93-1.03), and no significant association was found in subgroup analysis. A
linear but not significant dose-response association was found between black tea consumption and breast cancer
risk. Based on the current evidence, black tea and green tea might not contribute significantly to breast cancer risk,
respectively.
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The most recent meta-analysis by Ogunleye et al.
(Ogunleye et al. 2010) included 7 (2 cohort and 5 case-
control) studies of green tea and breast cancer that were
published as of December 2008. An inverse association
between green tea and breast cancer risk was reported
from case-control studies [compared to the lowest quan-
tile, the relative risk (RR) for the highest quantile of green
tea is 0.81, 95% CI = 0.75-0.88], while no association was
observed from cohort studies (compared to the lowest
quantile, the RR for the highest quantile of green tea is
0.85, 95% CI = 0.65-1.22), and the authors concluded that
the association between green tea consumption and breast
cancer risk remains unclear. Meanwhile, Zhou et al.
(Zhou et al. 2011) suggested that a dose-response analysis* Correspondence: zhangdf1962@yahoo.com.cn
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in any medium, provided the original work is pshould be performed to assess the association between
green tea and breast cancer risk. In another meta-analysis
on black tea and breast cancer risk, Sun et al. (Sun et al.
2006) included 13 (5 cohort and 8 case-control) studies
that were published as of August 2004. A moderate posi-
tive association between black tea consumption and risk
of breast cancer was observed in cohort studies (com-
pared to the lowest quantile, the RR for the highest quan-
tile of black tea is 1.15, 95% CI = 1.02-1.31) whereas a
minor inverse association was observed from the case-
control studies (compared to the lowest quantile, the RR
for the highest quantile of black tea is 0.91, 95% CI = 0.84-
0.98). Following the meta-analyses by Ogunleye et al.
(Ogunleye et al. 2010), results were published from 2 pro-
spective cohort studies (Iwasaki et al. 2010; Dai et al.
2010) on the association of green tea with risk of breast
cancer. And since the meta-analysis by Sun et al. (Sun
et al. 2006), results were published from 9 prospective
cohort studies (Harris et al. 2012; Fagherazzi et al. 2011;pen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 The multivariate-adjusted risk of breast cancer for the highest vs. lowest categories of green tea consumption. D + L denotes
random effect model, I-V denotes fixed effect model.
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2009; Ishitani et al. 2008; Ganmaa et al. 2008; Hirvonen
et al. 2006; Adebamowo et al. 2005) and 3 case-control
studies (Yuan et al. 2005; Kumar et al. 2009; Baker et al.
2006) on the association of black tea with breast cancer
risk. Besides, we also would like to draw attention to the
dose-response analysis, because categories of tea con-
sumption differed between studies, which might compli-
cate the interpretation of the pooled results across study
populations with different categories. In this respect, a
dose–response meta-analysis with restricted cubic spline
functions provides a solution to the problem (Desquilbet
& Mariotti 2010), from which a summary risk estimate
can be derived for a standardized increase and specific
exposure values for tea consumption.Figure 2 The dose-response analysis between green tea
consumption and breast cancer risk. The solid line and the long
dash line represent the estimated relative risk and its 95% confidence
interval. Short dash line represents the linear relationship.We performed a literature search to October 2012
using the databases of Pubmed, ISI Web of Knowledge,
China Biology Medical literature database and Google
Scholar with the key words tea consumption combined
with breast cancer. Furthermore, the reference lists of
retrieved articles were scrutinized to identify additional
relevant studies. If data were duplicated in more than 1
study, we included the study with the largest number of
cases. RR estimates with corresponding 95% CI for the
highest vs. lowest categories of tea consumption were
extracted. For dose-response analysis, the number of
cases and participants (person-years), and RR (95% CI)
for each category of tea consumption were also ex-
tracted. The median or mean level of tea consumption
for each category was assigned to corresponding RR for
every study. If the upper boundary of the highest cat-
egory was not provided, we assumed that the boundary
had the same amplitude as the adjacent category. We
extracted the RR that reflected the greatest degree of
control for potential confounders.
Pooled measure was calculated as the inverse
variance-weighted mean of the logarithm of RR with
95% CI to assess the strength of association between tea
consumption and breast cancer risk. The I2 of Higgins
and Thompson was used to assess heterogeneity
(I2 values of 0, 25%, 50%, and 75% represents no, low,
moderate, and high heterogeneity (Higgins et al. 2003),
respectively). The fixed effect model was used as the
pooling method if moderate or lower heterogeneity (I2 <
50%) was found, otherwise, the random effect model was
adopted (I2 ≥ 50%). Besides, combining studies regardless
of the between-study heterogeneity had been widely cri-
ticized (Lau et al. 1998), and hierarchical systems for
Figure 3 The multivariate-adjusted risk of breast cancer for the highest vs. lowest categories of black tea consumption. D + L denotes
random effect model, I-V denotes fixed effect model.
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be consistent or homogeneous to obtain the highest
grading (Harbour & Miller 2001). Thus, sensitivity
analysis was also carried out using the method by
Patsopoulos et al. (Patsopoulos et al. 2008) with I2 >
50% as the criteria to reduce between-study heterogen-
eity. Publication bias was detected using Egger’s linear
regression test (Egger et al. 1997).Figure 4 The dose-response analysis between black tea
consumption and breast cancer risk. The solid line and the long
dash line represent the estimated relative risk and its 95% confidence
interval. Short dash line represents the linear relationship.A two-stage random-effects dose–response meta-
analysis (Orsini et al. 2012) was performed to compute
the trend from the correlated log RR estimates across
levels of tea consumption taking into account the
between-study heterogeneity. Briefly, a restricted cubic
spline model, with 3 knots at the 25th, 50th and 75th
percentiles (Harrell et al. 1988) of the levels of tea con-
sumption was estimated using generalized least square
regression taking into account the correlation within
each set of published RRs (Orsini & Bellocco 2006).
Then multivariate random-effects meta-analysis was
used to combine the study-specific estimates using re-
stricted maximum likelihood method (Jackson et al.
2010). A P value for nonlinearity was calculated by test-
ing the null hypothesis that the coefficient of the second
spline is equal to 0. If tea consumption was indicated by
gram of tea leaves or tea beverage, we rescaled tea con-
sumption to the number of cups per day assuming 2.5 g
tea leaves or 150 g tea beverage as approximately
equivalent to one cup (Tang et al. 2009). All statistical
analyses were performed with Stata software, version 12
(Stata Corp, College Station, Texas). P < .05 was consi-
dered statistically significant.
For green tea, data from 9 studies (Iwasaki et al. 2010;
Dai et al. 2010; Shrubsole et al. 2009; Inoue et al. 2008;
Zhang et al. 2007; Suzuki et al. 2004; Wu et al. 2003;
Key et al. 1999; Tao et al. 2002) were used. Compared to
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highest quantile of green tea was 0.82 (0.64-1.04), and
high between-study heterogeneity was found (I2 = 78.1%)
(Figure 1). After sensitivity analysis with I2 > 50% as the
criteria, the association was still not significant (RR = 0.96,
95% CI = 0.86-1.08). No significant association was found
among cohort studies (RR = 1.03, 95% CI = 0.83-1.29,
I2 = 0.00%). A marginally significant association was found
among case-control studies (RR = 0.70, 95% CI = 0.50-0.98,
I2= 86.5%), however, the association was not significant
after sensitivity analysis (RR = 0.98, 95% CI = 0.86-1.13,
I2 = 0.00%). Data from 7 studies (Iwasaki et al. 2010;
Dai et al. 2010; Shrubsole et al. 2009; Zhang et al. 2007;
Suzuki et al. 2004; Wu et al. 2003; Key et al. 1999) were
used for dose-response analysis. A linear (P = 0.55) but
not significant dose-response association was found
between green tea consumption and breast cancer risk
(Figure 2), and the risk of breast cancer decreased by
3% (RR = 0.97, 95% CI = 0.90-1.04, P = 0.39) for every 2
cups/day increment in green tea consumption. The RR
(95% CI) of breast cancer was 0.97 (0.91-1.03), 0.94
(0.86-1.04), 0.93 (0.84-1.04), 0.93 (0.83-1.03), 0.92 (0.81-
1.04) and 0.91 (0.79-1.04) for 1, 2, 3, 4, 5 and 6 cups/day
of green tea consumption. No publication bias was
detected (P = 0.68).
For black tea, data from 25 studies (Harris et al. 2012;
Fagherazzi et al. 2011; Boggs et al. 2010; Bhoo Pathy
et al. 2010; Larsson et al. 2009; Ishitani et al. 2008;
Ganmaa et al. 2008; Hirvonen et al. 2006; Adebamowo
et al. 2005; Yuan et al. 2005; Kumar et al. 2009; Baker
et al. 2006; Suzuki et al. 2004; Wu et al. 2003; Key et al.
1999; Michels et al. 2002; Zheng et al. 1996; Goldbohm
et al. 1996; Mannisto et al. 1999; McLaughlin et al. 1992;
Ewertz & Gill 1990; Schairer et al. 1987; Lubin et al.
1985; Tavani et al. 1998; Rosenberg et al. 1985) were
used. Compared to the lowest quantile, the RR of breast
cancer for the highest quantile of black tea was 0.98,
95% CI = 0.93-1.03, I2 = 42.1%) (Figure 3). The association
was also not significant in subgroups by study design
categorized as cohort studies (RR = 1.02, 95% CI = 0.95-
1.09, I2 = 45.7%) and case-control studies (RR = 0.94,
0.87-1.00, I2 = 32.2%), menopausal status categorized as
premenopausal status (RR = 0.92, 95% CI = 0.77-1.08,
I2 = 15.6%) and postmenopausal status (RR = 1.07, 95%
CI = 0.96-1.21, I2 = 0.00%), estrogen receptor (ER) and
progesterone receptor (PR) status (negative: -; positive: +)
categorized as ER+/PR + (RR = 1.03, 95% CI = 0.80-1.34,
I2 = 63.9%) and ER-/PR- (RR = 0.84, 95%CI = 0.68-1.03,
I2 = 0.00%), as well as body mass index (BMI) catego-
rized as BMI < 25 kg/m2 (RR = 0.98, 95%CI = 0.81-1.18,
I2 = 51.2%) and BMI > 25 kg/m2 (RR = 1.02, 95% CI = 0.84-
1.24, I2 = 0.00%). After sensitivity analysis with I2 >
50% as the criteria, the association was still not sig-
nificant for ER+/PR + breast cancer (RR = 0.93, 95%CI = 0.82-1.05, I2 = 0.00%), and no significant association
was found among subjects with BMI < 25 kg/m2 (RR = 1.07,
95% CI = 0.86-1.33, I2 = 0.00%). Data from 19 studies
(Harris et al. 2012; Fagherazzi et al. 2011; Boggs et al.
2010; Bhoo Pathy et al. 2010; Larsson et al. 2009;
Ganmaa et al. 2008; Hirvonen et al. 2006; Adebamowo
et al. 2005; Kumar et al. 2009; Baker et al. 2006; Wu
et al. 2003; Key et al. 1999; Michels et al. 2002; Zheng
et al. 1996; Goldbohm et al. 1996; Ewertz & Gill 1990;
Schairer et al. 1987; Lubin et al. 1985; Rosenberg et al.
1985) were used for dose-response analysis. A linear
(P = 0.09) but not significant dose-response association
was found between black tea consumption and breast
cancer risk (Figure 4), and the risk of breast cancer de-
creased by 1% (RR = 0.99, 95% CI = 0.96-1.03, P = 0.68)
for every 2 cups/day increment in black tea consump-
tion. The RR (95% CI) of breast cancer was 1.02 (0.99-
1.05), 1.01 (0.98-1.05), 0.99 (0.95-1.03), 0.97 (0.92-1.02),
0.95 (0.89-1.01) and 0.93 (0.85-1.01) for 1, 2, 3, 4, 5 and
6 cups/day of black tea consumption. No publication
bias was detected (P = 0.79).
Overall, this analysis suggested that black tea and
green tea might not contribute significantly to breast
cancer risk based on the current evidence, respectively.
However, further researches deserve to address the pos-
sible interaction effects between tea and other dietary/
genetic cofactors.
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